Sahlgrenska Hospital invests in precision diagnostics with Qlucore InsightsQlucore, a driving force in software development for precision diagnostics of cancer, has signed an agreement with Sahlgrenska Hospital in Gothenburg, Sweden. The hospital will use the Qlucore Insights software to improve the diagnosis of acu.
Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK. As a leading pharmaceutical company engaged in research and development across multiple locations worldwide and a previous customer of Qlucore.
Precision cancer diagnostics software developer Qlucore has initiated a performance evaluation study in Sweden and Denmark as a significant and crucial step towards obtaining a CE marked solution, with results from the study expected early in 2024. Click to read more.
Data visualisation: past, present and futureQlucore is a leading provider of new generation bioinformatics software for research, and precision and companion diagnostics. Founded in 2007 by scientists inspired to simplify the process of data analysis for researchers, the company has worked with a number of Universit.
Qlucore, listed on Nasdaq First North and a developer of visualization-based software for research-focused data analysis and precision diagnostics, has received a grant of SEK 200,000 from innovation agency Vinnova through the strategic innovation program Medtech4Health. The program's mission is to implement more .